Skip to content

Kodiak Sciences Inc KOD Return on assets

Return on assets at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
11.3%-1.2pp
HRO
HarrowHROW
-10.5%+5.0pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-49.7%+2.2pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-51%+17.1pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-39.9%-56.4pp
Vera Therapeutics logo
Vera TherapeuticsVERA
-59.9%+187pp

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Calculated from Kodiak Sciences Inc’s reported figures.

Based on trailing twelve months.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's return on assets?
Kodiak Sciences Inc (KOD) reported return on assets of -76.4% in Q1 2026.
How has Kodiak Sciences Inc's return on assets changed year-over-year?
Kodiak Sciences Inc's return on assets decreased by 46.8% year-over-year, from -52% to -76.4%.
What is the long-term trend for Kodiak Sciences Inc's return on assets?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's return on assets has grown at a 29.1% compound annual growth rate (CAGR), from -18.7% to -66.9%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.